Onconetix annual current ratio
2021
2022
2023
2024
2025
Onconetix Current Ratio Growth & History (ONCO)
Onconetix's current ratio was 0.66 for fiscal 2025.
View full Onconetix company overviewOnconetix annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.66 | 0.61 | +1178.13% |
| 2024 | 2024-12-31 | 0.05 | −0.29 | −84.70% |
| 2023 | 2023-12-31 | 0.34 | −6.35 | −94.93% |
| 2022 | 2022-12-31 | 6.69 | 4.82 | +256.83% |
| 2021 | 2021-12-31 | 1.88 | — | — |
Onconetix quarterly current ratio
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 2.21 | 2.14 | +2919.95% |
| Q1 2026 | 2026-03-31 | 1.41 | 1.24 | +719.10% |
| Q4 2025 | 2025-12-31 | 0.66 | 0.61 | +1178.13% |
| Q3 2025 | 2025-09-30 | 0.08 | 0.02 | +32.27% |
| Q2 2025 | 2025-06-30 | 0.07 | −0.03 | −25.79% |
| Q1 2025 | 2025-03-31 | 0.17 | −0.12 | −41.29% |
| Q4 2024 | 2024-12-31 | 0.05 | −0.29 | −84.70% |
| Q3 2024 | 2024-09-30 | 0.06 | −0.48 | −88.83% |
| Q2 2024 | 2024-06-30 | 0.10 | −0.84 | −89.49% |
| Q1 2024 | 2024-03-31 | 0.29 | −7.71 | −96.33% |
| Q4 2023 | 2023-12-31 | 0.34 | −6.35 | −94.93% |
| Q3 2023 | 2023-09-30 | 0.54 | −6.24 | −92.03% |
| Q2 2023 | 2023-06-30 | 0.94 | −6.75 | −87.77% |
| Q1 2023 | 2023-03-31 | 8.00 | 1.18 | +17.32% |
| Q4 2022 | 2022-12-31 | 6.69 | 4.82 | +256.83% |
| Q3 2022 | 2022-09-30 | 6.78 | — | — |
| Q2 2022 | 2022-06-30 | 7.69 | — | — |
| Q1 2022 | 2022-03-31 | 6.82 | — | — |
| Q4 2021 | 2021-12-31 | 1.88 | — | — |
Onconetix current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Onconetix's current ratio decreased from 1.88 to 0.66, a change of −1.21. The latest reported quarter, Q2 2026, shows 2.21.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Onconetix source filings ↗